Nodexon (Dexamethasone)

Dexamethasone, the active ingredient in Nodexon, is a corticosteroid presented as an oral formulation for systemic use. It is employed to reduce inflammation and modulate immune responses in a range of conditions, including autoimmune diseases, severe allergic reactions, certain skin disorders, specific cancers, and severe COVID‑19 cases.

GNH USA supplies Nodexon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures reliable delivery across EU and global markets.

Dexamethasone, a glucocorticoid, exerts anti‑inflammatory and immunosuppressive effects across several disease categories.

Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. Severe asthma exacerbations: diminishes airway inflammation and improves breathing. Dermatitis (e.g., eczema, psoriasis): alleviates skin inflammation and lesions. Certain hematologic cancers (e.g., leukemia, lymphoma): part of chemotherapy regimens to control inflammation and tumor‑associated edema. Severe COVID‑19: mitigates cytokine storm and respiratory inflammation.

Oral dexamethasone may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Increased appetite - Weight gain - Mood changes - Insomnia - Elevated blood glucose - Gastrointestinal discomfort

Serious or Rare Side Effects: - Severe infection - Osteoporosis or fractures - Adrenal suppression - Psychosis or severe mood disorders - Peptic ulcer bleeding - Cataracts or glaucoma

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

Assess infection risk: monitor for signs of bacterial, fungal or viral infections. Screen for diabetes: check blood glucose before and during therapy. Evaluate bone health: consider calcium and vitamin D supplementation in long‑term use. Monitor psychiatric status: watch for mood swings, depression or psychosis. Avoid abrupt discontinuation: taper dose under medical supervision to prevent adrenal insufficiency. Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Dexamethasone can interact with several drug classes; careful assessment is required.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, phenytoin): may markedly reduce dexamethasone exposure. - Live vaccines: concurrent use can increase risk of disseminated infection. - Anticoagulants (e.g., warfarin): glucocorticoids may potentiate anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastrointestinal ulceration. - Diuretics (e.g., furosemide): may enhance hypokalemia. - Antidiabetic agents: dexamethasone can raise blood glucose, requiring dose adjustment.